2m 2m 2m 2m 2m 2m 2m
AbbVie (ABBV)
NYSE
$233.54+$3.53 (+1.53%)
Price as of Jun 23, 2026 3:13 PM EDT- $406.4BMarket Cap
- 29.25%1-Year Change
- Drug Manufacturers - GeneralIndustry
AbbVie (ABBV)
$233.54+$3.53 (+1.53%)
ABBV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $230.01 | ||
Change | +$13.52 (+6.25%) | ||
Open | $221.94 | ||
High | $232.32 | ||
Low | $221.94 | ||
Previous Close | $216.49 | ||
Volume | 9,912,803 | ||
30-Day Average Volume | 5,787,473 | ||
1-Week Change | 3.80% | ||
1-Month Change | 6.63% | ||
1-Year Change | 29.25% | ||
3-Year Change | 86.39% | ||
5-Year Change | 141.89% | ||
Fundamentals | |||
Shares Outstanding | 1.8B | ||
Total Assets | $136.5B | ||
Market Cap | $406.4B | ||
Enterprise Value | $469.8B | ||
Period: QTR TTM FY | |||
Revenue | $15.0B | ||
Net Income | $695.0M | ||
Free Cash Flow | $3.6B | ||
EBIT | $1.7B | ||
EBITDA | $3.4B | ||
Net Working Capital | -$8.6B | ||
EPS | $0.39 | ||
Enterprise Value/EBITDA | 137 | ||
Enterprise Value/Revenue | 31 | ||
P/B | -61 | ||
P/E | 590 | ||
PEG | -10 | ||
Price/Free Cash Flow | 114 | ||
Price/Operating Cash Flow | 106 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 3.01% | ||
Trailing Annual Dividend Yield | 2.93% | ||
Ex-Dividend Date | 07/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield